ArticleAnnals of translational medicine2021

Successful treatment of EGFR T790M-mutant non-small cell lung cancer with almonertinib after osimertinib-induced interstitial lung disease: a case report and literature review.

Longqiu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.